◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Mega Genomics Limited (6667) Financial History

Name: Mega Genomics Limited (6667) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-10

Mega Genomics Limited (6667) operates in the Diagnostics & Research industry and is headquartered in Beijing, China with about 206 employees. Its market capitalization is roughly CNY 2 billion. In the fiscal year ended 2025-12-31, 6667 reported CNY 247M in revenue and CNY 27M in net income.

Mega Genomics Limited, a genetic testing platform company, offers consumer genetic testing and cancer screening services in China.

Interactive charts & full statements →

6667 Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	CNY 247M	CNY 164M	CNY 151M	CNY 146M	—
Gross Profit	CNY 117M	CNY 119M	CNY 88M	CNY 82M	—
Operating Income (EBIT)	CNY 39M	CNY 41M	CNY 18M	CNY 5M	—
Net Income	CNY 27M	CNY 45M	CNY 30M	(CNY 18M)	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6667 Free Cash Flow History

6667 Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	CNY 832M	CNY 738M	CNY 796M	CNY 706M	—
Total Liabilities	CNY 222M	CNY 124M	CNY 152M	CNY 88M	—

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6667 viewer.

Other Companies in Diagnostics & Research

CDNA · CareDx, Inc. — $2 billion
2427 · Guanze Medical Information Industry (Holding) Co., Ltd. — $2 billion
NEO · NeoGenomics, Inc. — $2 billion
WGS · GeneDx Holdings Corp. — $2 billion
PSNL · Personalis, Inc. — $2 billion
OPK · OPKO Health, Inc. — $1 billion
CSTL · Castle Biosciences, Inc. — $979 million
LBIRD · Lumibird SA — $626 million

← 6666 All “0-9” companies 6668 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.